False-positive rifampicin resistance on Xpert® MTB/RIF: case report and clinical implications [Technical note]
Keywords: MDR-TB; assay performance; false-positive rifampicin resistance; tuberculosis
Document Type: Research Article
Affiliations: 1: Department of Epidemiology, University of North Carolina, Chapel Hill, North Carolina, USA 2: Right to Care, Johannesburg, South Africa 3: Clinical Microbiology and Infectious Diseases, University of Witwatersrand, Johannesburg, South Africa; and National Health Laboratory Services, Johannesburg, South Africa 4: National Health Laboratory Services, Johannesburg, South Africa; and Department of Molecular Medicine and Haematology, University of the Witwatersrand, Johannesburg, South Africa 5: Witkoppen Health and Welfare Centre, Fourways, Gauteng, South Africa 6: Department of Science and Technology, National Research Foundation Centre of Excellence for Biomedical Tuberculosis Research, Medical Research Council Centre for Molecular and Cellular Biology, Division of Molecular Biology and Human Genetics, Faculty of Health Sciences, Stellenbosch University, Cape Town, South Africa
Publication date: 01 February 2012
The International Journal of Tuberculosis and Lung Disease (IJTLD) is for clinical research and epidemiological studies on lung health, including articles on TB, TB-HIV and respiratory diseases such as COVID-19, asthma, COPD, child lung health and the hazards of tobacco and air pollution. Individuals and institutes can subscribe to the IJTLD online or in print – simply email us at [email protected] for details.
The IJTLD is dedicated to understanding lung disease and to the dissemination of knowledge leading to better lung health. To allow us to share scientific research as rapidly as possible, the IJTLD is fast-tracking the publication of certain articles as preprints prior to their publication. Read fast-track articles.
- Editorial Board
- Information for Authors
- Subscribe to this Title
- International Journal of Tuberculosis and Lung Disease
- Public Health Action
- Ingenta Connect is not responsible for the content or availability of external websites
- Access Key
- Free content
- Partial Free content
- New content
- Open access content
- Partial Open access content
- Subscribed content
- Partial Subscribed content
- Free trial content